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1. Introduction 
Schistosomiasis and soil-transmitted helminthiasis (STH) are the most common types of 
parasitic infections in the world. These diseases have major health and socio-economic 
repercussions, and constitute an important public health problem in developing countries. 
Human schistosomiasis is caused by six species of schistosomes, i.e. Schistosoma haematobium, 
Schistosoma mansoni, Schistosoma japonicum, Schistosoma mekongi, Schistosoma intercalatum and 
Schistosoma guineensis; and is endemic in 78 countries, where 779 million people are at risk of 
infection. S. haematobium is responsible for urogenital schistosomiasis, and the other species 
cause intestinal schistosomiasis. It is estimated that 207 million people are infected (WHO, 
2002; Steinmann et al. 2006). STH, also known as intestinal worm infection, is caused by four 
main species of worms commonly known as roundworms (Ascaris lumbricoides), whipworms 
(Trichuris trichiura) and hookworms (Ancylostoma duodenale and Necator americanus). It is 
estimated that STH affects more than 2 billion people worldwide, and the greatest numbers of 
infections occur in sub-Saharan Africa, the Americas, China and east Asia (WHO, 2006; Hotez 
et al., 2006; Brooker et al., 2006; Awasthi et al., 2003). 
These diseases affect the poorest of the poor and infections are particularly abundant among 
people living in rural or deprived urban settings with low socio-economic status, lack of 
clean water and poor sanitation (Hotez et al., 2006). The morbidity caused by these worms is 
commonly associated with heavy infection intensities. Compared with any other age group, 
school-aged children and pre-school children are the most vulnerable group and they 
harbor the greatest numbers of intestinal worms. As a result, they experience growth 
stunting and diminished physical fitness as well as impaired memory and cognition 
(Crompton and Nesheim, 2002; Stephenson et al., 2000; Bethony et al., 2006). These adverse 
health consequences combine to impair childhood educational performance and reduce 
school attendance (Miguel & Kremer, 2004; Hotez et al., 2008). Studies have demonstrated 
that children may acquire helminth infections early in life (Sousa-Figueiredo et al., 2008; 
Stothard et al., 2008); which causes initial organ damage that can remain subclinical for 
years and manifest overtly only later, in adulthood (WHO, 2006; Odogwu et al., 2006). 
Despite the existence of tools in the 1970s and 1980s, control was sustained for a prolonged 
period only in few countries and almost no progress was made in sub-Saharan African 
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countries, the most affected part of the world. In the 1990s, interest in the control of these 
diseases in Africa waned. Therefore, as with other neglected tropical diseases (NTDs), 
schistosomiasis and STH control has been overshadowed by other health priorities. The 
highest priority of the international health community was given to the ‘big three’, i.e. 
HIV/AIDS, tuberculosis and malaria, with less attention to other infections related to 
poverty (Molyneux et al., 2005). 
Recent years have witnessed an increased interest in the control of NTDs, and today there 
exists a global momentum for the control of these diseases. The control of NTDs has become 
a priority on the agenda of many governments, donors and international agencies. The 
World Health Organization (WHO) has played a major role in this prospect. Indeed, under 
the aegis of WHO, all member states of WHO (over 200 countries) have endorsed in May 
2001 the World Health Assembly resolution WHA 54.19, with as a major objective the 
regular treatment of at least 75% of all school-aged children at risk of morbidity by 2010. The 
renewed impetus for schistosomiasis and STH control has generated a greater political 
commitment, as well as an unprecedented opportunity for cost-effective action (Molyneux et 
al., 2005). This momentum has encouraged many countries to establish national action plans 
and programmes to control schistosomiasis, STHs and other NTDs (Hotez et al., 2009; 
Tchuem Tchuenté & N'Goran, 2009). Within the past decade, significant progress has been 
made on large scale treatments through integrated control of schistosomiasis, STH and other 
NTDs, thanks to a number of international organizations, donor foundations, bilateral 
institutions and non-governmental organizations that responded to the 2001 WHO's call for 
action (Savioli et al., 2009). Today, treatment is cost-effective and the ‘preventive 
chemotherapy’ is currently the strategy of choice (WHO, 2006). With a support from the 
American (USAID) and British (DFID) governments, as well as the Bill and Melinda Gates 
Foundation, the pharmaceutical industry, and many not-for profit organizations, millions of 
children are regularly treated for schistosomiasis, STH and other NTDs. However, the 
control of these diseases is a long-term undertaking which involves several challenges. This 
paper highlights the progress made and also focuses on some main challenges that are 
reviewed and discussed. 
2. Epidemiology and burden of schistosomiasis and STH 
Schistosomiasis and STH transmission are intimately associated with poverty and poor 
sanitation. For schistosomiasis, infecion is caused by penetration of the skin by larvae in 
water; whereas for STH, infection is caused by the ingestion of parasite eggs from 
contaminated food or dirty hands – in the case of A. lumbricoides and T. trichiura – or by 
active penetration of the skin by larvae in the soil – in the case of hookworms. People who 
get infected carry parasite eggs in the feces or in the urine (in the case of urinary 
schistosomiasis), and in areas where there is no latrine systems the soil and water around 
the villages and communities are contaminated with feces or urine containing worm eggs. 
Although schistosomiasis and STH infections occur predominantly in rural areas, the social 
and environmental conditions in many unplanned slums and squatter settlements of 
developing countries are ideal for their persistence (Crompton & Savioli, 1993). In endemic 
populations, infections are aggregated: most infected individuals in a community will have 
infections of a light or moderate intensity, while a few will be heavily infected. Heavily 
infected individuals suffer most of the clinical consequences of the infections and are the 
major source of infection for the rest of the community (WHO, 2002). 
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The epidemiology of helminth infections is influenced by several key determinants, 
including environment, population heterogeneity, age, household clustering, genetics and 
polyparasitism (Hotez et al., 2008). In recent years, considerable progress has been made in 
the use of geographical information system (GIS) and remote sensing (RS) to better 
understand helminth ecology and epidemiology, and to develop low-cost ways to identify 
target populations for treatment. GIS and RS were used to describe the global distribution of 
schistosomiasis and STH infections and to estimate the number of infections in school-age 
children in sub-Saharan Africa. 
There is considerable geographical variation in the occurrence of infections (Brooker et al., 
2009). In general, changes with age in the average intensity of helminth infections tend to be 
convex, rising in childhood and declining in adulthood. For schistosomiasis, A. lumbicoides 
and T. trichiura, the heaviest and most frequent infections are in children aged 5–15 years, 
with a decline in intensity and frequency in adulthood (Gilles, 1996). In contrast, hookworm 
frequently exhibits a steady rise of intensity of infection with age, peaking in adulthood 
(Bethony et al., 2002). Household clustering of infected individuals has been demonstrated 
for STH (Forrester et al., 1988), and this can persist through time, as shown by familial 
predisposition to heavy infection with A. lumbricoides and T. trichiura (Forrester et al., 1990). 
Because morbidity is associated with worm burden rather than the absence or presence of 
infection, prevalence is commonly combined with worm burden (intensity of infection) to 
assess the epidemiological situation for schistosomiasis and STH infections. Worm burden is 
commonly measured by the number of eggs per gram (EPG) of feces or eggs per 10ml of 
urine (Anderson, 1982; Montresor et al., 1998). Prevalence and intensity of infections are 
used to classify communities into transmission categories, which enable to determine the 
appropriate type of mass treatment a community should receive (WHO, 2006). Both should 
be assessed in monitoring the impact of deworming campaigns. 
3. Control of schistosomiasis and STH 
3.1 Progress towards the 2010 global target 
Progress in implementing schistosomiasis and STH control programmes has been slow but 
steady. Since 2006, there has been an overall increase in the number of people treated for 
schistosomiasis and STH. The increase in treatments has occurred entirely in the African 
Region, where the number of people treated more than doubled from 2006 to 2009 (WHO, 
2011). This number increased by 93% in 2010. The increase in the number treated suggests that 
both governments and their donor partners are now investing in schistosomiasis control 
(WHO, 2012). In 2010, 18 over 42 schistosomiasis endemic countries in the African region and 
34/46 STH endemic countries or territories reported their treatment data to WHO. Overall, 
27,983,327 people were treated for schistosomiasis, and 91,025,863 children for STH (Table 1). 
 
Characteristics Schistosomiasis STH 
No. endemic countries 42 46 
No. countries reporting MDA data 18 34 
No. people requiring treatment 220 578 484 283 800 000 
No. people treated 27 983 327 91 025 863 
No. pre-school aged children treated - 42 711 551 
No. school aged children treated - 48 314 312 
Table 1. African Regional summary of children treated for schistosomiasis and STH, 2010 
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Figure 1 illustrates the progress in Africa ten years after the 2001 WHA resolution. Although 
significant progress has been made over the past years to significantly reduce 
schistosomiasis and STH infection prevalence below low risk, or to regularly implement 
mass drug administration (MDA) in several countries, the global achievement is still very 
far from the WHO’s target of regular deworming of at least 75% of school-age children at 
risk. Indeed, from the data of epidemiological coverage of STHs, it was estimated that only 
15% of school-aged children at risk of infection have been treated with preventive 
chemotherapy in 2008 (WHO, 2010). School-based deworming interventions still cover only 
a minority of children considered to be at risk despite the low cost of these interventions and 
their significant impact on health. More worrying, the number of people treated for 
schistosomiasis in Sub-Saharan Africa is estimated to be only 6.71% of the people infected 
(WHO, 2011). The major constraint to controlling schistosomiasis continues to be the limited 
access to praziquantel (Hotez et al., 2010). In the African Region, only few countries (18 in 
2008) have achieved the 75% treatment target. 
3.2 Taking advantage of integrated control of NTDs 
In the developing world, polyparasitism is the norm rather than the exception (Molyneux et 
al., 2005; Fleming et al., 2006; Tchuem Tchuenté et al., 2003). In large parts of the world, 
particularly in Africa, most children are infected by more than one species of helminth. 
These NTDs frequently overlap geographically and they impose a great burden on poor 
populations, affecting the same individuals. Therefore, the current strategy for NTD control 
is to integrate interventions for multiple diseases (Molyneux et al., 2005). This integrated 
approach is the basis for cost-effectiveness and streamlined efficiency. Also, because many 
of the drugs used for mass treatment are provided free of charge by major multinational 
pharmaceutical companies, the MDA approach is the most cost-effective global public 
health control measure (Hotez et al., 2007). Schistosomiasis and STH infections are the most 
prevalent and widespread of the common NTDs, and they overlap in many parts with many 
of the other NTDs. Therefore, an integration of schistosomiasis and STH control with other 
helminth control programmes and a good coordinated use of (donated) drugs would be 
highly beneficial for their control. This would indeed allow to take advantage of drug 
donation and co-administration, and to optimize the preventive chemotherapy.  
Within the past decade, significant progress has been made on large-scale treatment of 
schistosomiasis and STH through integrated control with other NTDs, thanks to a number 
of international organizations, donor foundations, bilateral institutions and non-
governmental organizations that responded to the 2001 WHO’s call for action (Savioli et al., 
2009). With a support from the American (USAID) and British (DFID) governments, as well 
as the Bill and Melinda Gates Foundation, the pharmaceutical industry, and many not-for 
profit organizations, millions of children are regularly treated for schistosomiasis, STH and 
other NTDs. Today, an integrated control of NTD using the preventive chemotherapy is 
operating in more than 15 countries. Within the first three years (2006-2009) of 
implementation of the USAID NTD Control Program, the number of persons reached each 
year increased progressively, with a cumulative total of 98 million persons receiving 222 
million treatments (Linehan et al., 2011). In West Africa, nearly 13.5 million doses of 
albendazole have been administered against STH between 2004 and 2006 in Burkina Faso, 
Mali and Niger, with coverage rates varying between 67.0% and 93.9% (Garba et al., 2009). 
Monitoring and evaluation activities after large-scale administration of praziquantel for 
schistosomiasis and albendazole for STH showed a significant decrease in the intensity of 
infections. Also, there was a significant increase in haemoglobin concentration after 1 and 2  
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Fig. 1. Comparative status of schistosomiasis control in Africa at the end of the 20th century 
(A) and in 2010 (B). 
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years of treatment (Fenwick et al., 2009). Combination of ivermectin and albendazole, and 
co-administration of praziquantel and albendazole or mebendazole have been proven to be 
safe, with no side effects outside those commonly associated with each of these drugs 
(Horton et al., 2000; Olds et al., 1999). Though WHO does not formally recommends 
combination of praziquantel and ivermectin yet, recent studies have demonstrated the 
safety of triple co-administration of praziquantel, albendazole and ivermectin in areas 
where schistosomiasis, STH and LF or/and onchocerciasis are co-endemic and where 
several rounds of treatment with one or two drugs have been implemented in the past 
(Mohammed et al., 2008). 
3.3 A country example: Cameroon 
In Cameroon, schistosomiasis and STH are important parasitic diseases. Recent estimates 
indicate that at least 2 million people are infected with schistosomiasis, 5 million are at risk 
and more than 10 million are infected with gastrointestinal helminths (Minsante, 2005). In 
1983, a pilot project for schistosomiasis control, funded by USAID, was set up. Within this 
framework a national epidemiological survey of schistosomiasis and STH was conducted 
between 1985 and 1987. Overall, 49 divisions, 504 schools and 23 850 schoolchildren were 
investigated. The results showed the occurrence of S. haematobium, S. mansoni, S. guineensis, 
A. lumbricoides, T. trichiura and N. americanus as the major helminth species. The highest 
transmission levels of schistosomiasis occured in the northern part, whereas STH were more 
prevalent in the southern part of the country (Ratard et al., 1990, 1991; Brooker et al., 2000). 
When considering all these helminthic diseases, no region of the country is spared. 
However, this pilot project stopped in 1989 when the USAID support ended. 
Taking advantage of the renewed momentum  for NTDs, the national programme for the 
control of schistosomiasis and STH was created in March 2003. There is a strong political 
commitment from the Ministries of Public Health and Basic Education. These two ministries 
work in close collaboration and this inter-sectorial engagement is consolidated by the fact 
that the national steering committee for the control is co-chaired by the Minister of Public 
Health and the Minister of Basic Education, as president and vice-president, respectively. 
The Cameroonian proposal for support to SCI was presented by the Minister of Public 
Health himself who attended the SCI advocacy meeting in London in July 2003. Therefore, 
the non-selection of Cameroon for SCI support came both as a surprise and a 
disappointment. Beyond the main ranking criteria, including the existence of a strategic plan 
for control, the strong political commitment and the quality of the proposal, the SCI 
selection was finally made on a regional combination of three East African countries and 
three West African countries, with emphasis on country-regional collaboration and 
consortium. In spite of this, the Cameroonian government made necessary efforts to ensure 
the success of the schistosomiasis and STH control, as it was among the priority 
programmes of the country. Hence, the national control programme was officially launched 
on 25 March 2004. 
The action of the programme during the past few years was intense and multifaceted, with a 
number of key achievements. Based on the limited resources available, the priority activities 
were centred on three major activities: (1) the production of various strategic documents 
necessary for the implementation of the activities and advocacy; (2) the advocacy and the 
mobilisation of partners and funding; and (3) the implementation of activities in selected 
areas. A strong emphasis was put on advocacy, the results of which were encouraging for 
future activities and plans. The most important was the selection of Cameroon as the first 
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start-up country for mebendazole donation in Africa. Indeed, in 2005 Johnson & Johnson 
established a partnership with the Task Force for Child Survival and Development (currently 
The Task Force for Global Health) to develop a programme to donate mebendazole via a 
multi-disciplinary initiative designed to address intestinal worm infections in the most at-risk 
children of the world. Cameroon was selected as the start-up country for this drug donation 
programme because of its leadership and commitment to eliminating infections as a major 
public health problem (http://www.janssenpharmaceutica.be/download_Cameroen_N.asp). 
With regard to control, a pilot phase was completed in February 2006 in one health district, 
where approximately 20,000 school-aged children were treated with praziquantel and 
albendazole. Subsequently, the activities were extended to one entire region of the ten 
regions in Cameroon, i.e. the Adamawa region in the northern part of the country. This was 
implemented with support from partners, including the World Food Programme (WFP), the 
Canadian Co-operation, the United Nations International Children’s Emergency Fund 
(UNICEF) and SCI/Medpharm (which donated the drugs praziquantel and albendazole). 
Deworming was conducted in all 500 primary schools in this region, and approximately 
150,000 school-aged children were treated in May 2006. Overall, 700 head teachers, 500 
representatives of parent teacher associations, and 2500 teachers were trained. In addition, 
parasitological surveys for schistosomiasis and STH were conducted in 40 selected schools 
where stool and urine samples were collected from a total of 1830 children. 
The mebendazole donation enabled the national control programme to scale-up activities 
rapidly. As a result, deworming activities were increased to encompass all ten regions. In 
2007, Cameroon launched a nationwide deworming campaign, and 4 million school-aged 
children were treated. The launching ceremony allowed the government and partners to 
further reaffirm their commitment and to galvanise communities, international 
development agencies, non-governmental organisations (NGOs) and other stakeholders to 
join in the effort to implement fundamental improvements in disease control and 
prevention. The country has in place school-based and community-directed channels and in 
the programme teachers and community drug distributors administer the drugs to children 
along with health and hygiene education. The major activities conducted are: (1) training of 
health and education personnel, (2) sensitization and education of communities about the 
disease, the risks of infection and measures for prevention, (3) promotion of hygiene, safe 
water and sanitation systems in communities, and (4) deworming of children. Since 2007, 4 
million school-age children are treated annually with mebendazole, with the involvement of 
over 75,000 trained teachers and head teachers. Control of STH is primarily implemented 
through school-based distribution of mebendazole, co-administered with praziquantel 
where schistosomiasis is endemic. In addition, albendazole is co-administered with 
ivermectin during the community-directed treatment for LF. Furthermore, over 2.7 million 
children aged 1–5 years are dewormed during child health week campaigns implemented 
twice a year (Tchuem Tchuenté and N’Goran, 2009). 
Moreover, parasitological surveys were conducted in selected schools in all 63 health 
districts of the Centre, East and West regions of Cameroon, in order to update the disease 
distribution map, to assess the impact of previous deworming campaigns, and to determine 
where treatment with PZQ should be extended. The results showed significant variation of 
schistosomiasis and STH prevalence between schools, villages, districts and regions. In 
comparison to previous mapping data collected 25 years ago, the results showed an increase 
of schistosomiasis transmission in several health districts, where PZQ MDA was not 
implemented so far. On the contrary, there was a significant decline of STH infection 
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prevalence and intensities in all three regions, with an overall decline of prevalence from 
90.06% (95% CI: 89.45-90.63%) to 24.11% (95% CI: 23.37-24.86%). Based on the prevalence 
data, the continuation of annual or bi-annual MDA for STH was recommended, as well as 
an extension of PZQ treatment in identified moderate and high risk communities for 
schistosomiasis (Tchuem Tchuenté et al., 2012). These results show the positive impact of 
annual deworming campaigns, and illustrate the progressive success of the national 
programme for the control of schistosomiasis and STH in Cameroon. This is illustrated in 
Figure 2. Parasitological surveys are in progress in the remaining regions of Cameroon for 
the update mapping. 
4. Challenges 
The control of schistosomiasis and STHs is a long-term undertaking, which involves several 
challenges. The first challenge is to mobilize the funds required for successful actions. 
Unlike some of the stigmatising NTDs with ‘visible’ morbidity such as onchocerciasis and 
LF which have successfully raised funding for the implementation of control activities, little 
funding are globally available for the implementation of schistosomiasis and STH control 
alone. Therefore, for their schistosomiasis and STH control programmes, endemic countries 
should take advantage of the opportunities resulting from the global growing financial 
resources generated by the new partnerships and impetus for NTD control. The recent 
changes in the international agenda and the increasing funding opportunities provide 
leverage for the control of schistosomiasis and STHs. The piggyback and integrated control 
approaches – based on a complementary co-administration of relevant drugs – are the basis 
for cost-effectiveness and streamlined efficiency. However, pigging back on other 
interventions or integration with other health programmes requires the setting up of clear 
efficient coordination mechanisms in order to optimize the use of resources mobilized from 
various partners. Among other challenges, the most important are the co-ordination at 
various levels, the country ownership and leadership, the scale up of control, the 
sustainability of control programmes, the strengthening of partnerships and institutional 
capacities, the implementation of operational research, monitoring and evaluation, and the 
development of new diagnostic tools. 
4.1 Co-ordination 
The NTD control programmes involve many partners and stakeholders, different diseases, 
several funding sources, and multiform resources. The main challenge is to set up clear 
efficient coordination mechanisms in order to optimize the resources mobilised from all 
partners. To ensure transparency in all processes, there is a need for a coordination 
mechanism for funding, drug supplies and integrated control of NTDs to enable all 
stakeholders to share information. The coordination mechanism should be at global, 
regional and country levels. The precise form of this co-ordination mechanism needs to be 
explored and agreed amongst stakeholders. At national level, the Ministry of Health should 
play the central role in this co-ordination. 
4.2 Country ownership and leadership 
In order to ensure the sustainability and the success of NTD control programmes, country 
leadership in the coordination of activities is essential. Each partner may have its own vision 
and own interest, and the ones who bring the money also sometimes decide what to do.  
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Fig. 2. Comparative maps of the overall soil-transmitted helminthiasis prevalence between 
the years 1985-1987 (A) and 2010 (B) in the Centre, East and West regions of Cameroon. 
Sometimes, many people in a country are working for the same thing, but with different 
targets because there are different donors. Country ownership brings many gains, including 
development of local capacity and expertise. There should be a strong political commitment 
to tackle NTDs in endemic countries. Indeed, examples of success stories are from those 
countries (e.g. Japan, Morocco and China) that had clear ambitious goal, with high 
government and national commitment, funding mobilization and leadership. For example, 
in early 1963 STH occurred in Okinawa, Japan at high prevalence up to 40% in adult 
population. Through the development of an ambitious 'zero parasites' campaign a 
successful control was conducted and within a period less than 10 years STHs and other 
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parasites were eradicated in Okinawa. In contrary, lack of ambitious control is remarkable in 
Sub-Saharan Africa where many countries have passive attitude, waiting for partners to 
decide and to tell them what to do. African governments should develop more positive and 
ambitious approach for the control of NTDs, and donors and agencies beyond disease 
endemic countries—the agents of aid to developing countries—will need to accept that 
countries must have ownership of their health systems and total control over decisions 
about the health of their people. 
4.3 Scale up of control 
In order reach the target set by WHA for the different NTDs, there is a need to accelerate the 
extent of treatment. The extension of regular deworming coverage as a public health 
intervention to reach all individuals at risk remains a challenge. There is also a challenge to 
tackle the big countries such as Nigeria, Democratic Republic of Congo, Ethiopia and 
Tanzania which count for 60% of at risk population not covered by preventive 
chemotherapy yet. In the context of multi-disease integrated control, the current tendency in 
sub-Saharan Africa is to integrate helminth control within the community-directed 
interventions, taking advantages of the long experience and gains of onchocerciasis and LF 
control programmes through the establishment of community-directed treatment with 
ivermectin (CDTI) in all countries supported by the African Programme for Onchocerciasis 
Control – APOC (Sékétéli et al., 2002; Amazigo et al., 2002). Yet, in the majority of countries, 
STHs are more widely distributed than both onchocerciasis and LF. Therefore, the challenge 
will be to extend MDA coverage in those areas where CDTI does not exist. Countries should 
thus act cautiously and anticipate to avoid to neglect STH and schistosomiasis control in 
those endemic areas. School-based deworming is probably the simple, cost-effective and 
best sustainable way to expand coverage of children. With more schools than clinics, and 
more teachers than health workers, the existing and extensive education infrastructure 
provides the most efficient way to reach the highest number of school-age children and to 
reach the WHO target of covering at least 75% of all school-aged children in need. The 
recent increases of donated anthelminthic medicines by Merck KGaA (praziquantel), 
Johnson & Johnson (mebendazole) and GlaxoSmithKline (albendazole) constitute a real 
boost towards the achievement of this goal. 
4.4 Sustainability 
To roll back the NTDs, it is necessary to continue and maintain the implementation of 
control activities during very long period. The programme should be long-term, and 
financial and implementation plans should be made accordingly. This would avoid one of 
the major errors of the past where most of the programmes were supported by short-term 
external funds and stopped immediately when funds ceased. To ensure sustainability, 
countries should, from the beginning, envisage strategies to: (1) keep the momentum, 
interest and enthusiasm for the control of the diseases; (2) organize and finance in a 
sustained way the distribution of drugs to those who need them; (3) mobilize funding for 
operational costs for drug distribution, health education materials, baseline data collection, 
monitoring and evaluation, etc.; (4) ensure the availability and affordability of the drugs at 
community level in endemic areas; (5) integrate programme activities within the existing 
health structures and networks; and (6) strengthen the health system and national capacity 
at all levels, especially in the peripheral and remote areas which manage the greater number 
of communities and infected persons. One of the key questions is how to guarantee the 
continuation of control after the decline or interruption of external funds. 
www.intechopen.com
Control of Schistosomiasis and Soil-Transmitted  
Helminthiasis in Sub-Saharan Africa: Challenges and Prospects 369 
4.5 Strengthening of partnership 
An efficient control requires multisector collaboration and multilateral funding. No single 
organization can hope to achieve this goal alone. School-aged children are the target group 
for schistosomiasis and STH, so the collaboration between the Ministry of Health and the 
Ministry of Education should be reinforced. The target group for the different filarial 
infections is the entire population and the control strategy is based on community-directed 
interventions, which requires ownership by the communities and strong partnership with 
NGOs. Overall, partnership with other government departments and NGOs concerned with 
water supply, sanitation and development projects should be developed and reinforced. 
4.6 Strengthening of institutional capacities 
The integration of control activities within the health services is fundamental for the 
sustainability of the programme. However, most of the existing structures do not have the 
capacity to ensure the implementation of these activities, leading to programme failure. 
Therefore, the strengthening of the health system is a requirement for the long-term viability 
of the control programme. Furthermore, an efficient participation of schools and 
communities in the disease control requires a reinforcement of capacity of the school system 
and the community ownership. 
4.7 Operational research 
It is important to support operational research to fulfill gaps and improve the 
implementations of the control. For example, the understanding of some key issues, such as 
baseline epidemiology, morbidity assessment, drug efficacy testing and monitoring of drug 
resistance, is of vital importance. 
4.8 Monitoring and evaluation 
Regular monitoring and evaluation are necessary to ensure that programmes are efficiently 
implemented and that the beneficiaries gain the maximum benefit. This is particularly 
challenging given the diversity of tools and indicators. Substantial progress has been made 
towards the development of standardized tools for monitoring and evaluating NTD control 
programmes. WHO is currently developing guidelines based on the experience to date with 
integrated preventive chemotherapy interventions. 
4.9 Better diagnostic tools 
Because of its simplicity and relatively low-cost, the Kato–Katz technique (Katz et al., 1972) 
is widely used for epidemiological field surveys and is recommended by the WHO for 
surveillance and monitoring of schistosomiasis and STH control programmes (WHO, 1991; 
Montresor et al., 1998). Though the specificity is very high, the sensitivity of Kato–Katz in 
single stool sample examination is limited by day-to-day variation in egg excretion leading 
to measurement error in estimating the presence of infection. This is particularly 
accentuated in areas with high proportions of light intensity infections (Hall, 1981; Booth et 
al., 2003; Tarafder et al., 2009). In the current era of preventive chemotherapy, the 
intensification of large-scale interventions and repeated mass deworming will significantly 
reduce the prevalence and intensities of schistosomiasis and STH infections (Savioli et al., 
2004; Kabatereine et al., 2007). As consequence of the increase of low-intensity infections, 
more light infections will be often missed if single stool samples are examined by Kato–Katz 
method, resulting in high underestimation rates. Therefore, there is a need to develop and 
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validate more sensitive diagnostic tools for accurate surveillance and monitoring of 
schistosomiasis and STH control programmes, and for monitoring of drug efficacy. Some 
studies recommended multiple stool samples in order to avoid underestimating the ‘true’ 
prevalence and transmission potential of schistosomiasis and STH infections. Indeed, it was 
demonstrated that Kato–Katz examination of 3 instead of 1 stool specimen increased the 
sensitivity of helminth diagnosis, most notably for hookworm (Steinmann et al., 2008; 
Knopp et al., 2008) and intestinal schistosomiasis (De Vlas and Gryseels, 1992; Lin et al., 
2008). Recent studies suggested that urine circulating cathodic antigen (CCA) assays maybe 
an appropriate test for the diagnosis of S. mansoni in moderate transmission zones (Shane et 
al., 2011; Stothard et al., 2011; Tchuem Tchuenté et al., 2012). Several alternative stool 
examination techniques have been tested for the detection of STH infections. FLOTAC, a 
new technique mainly used in the veterinary field, was suggested as a suitable diagnostic 
tool particularly in situations of low parasite infection intensities (Cringoli, 2006). Recent 
studies found that a single FLOTAC examination was more sensitive than triplicate Kato–
Katz thick smears for the diagnosis of low-intensity STH infections (Knopp et al., 2009). In 
particular, the FLOTAC technique improves the ability to diagnose human hookworm 
infections accurately (Utzinger et al., 2008), which is generally underestimated when using 
Kato–Katz thick smears due to a rapid disintegration of hookworm eggs and the constraint 
to read the slides very shortly (within 30 min) after preparation (Dacombe et al., 2007). 
FLOTAC was thus suggested as a suitable method for a rigorous surveillance of helminth 
control programmes, monitoring of STH transmission and verification of local elimination 
(Knopp et al., 2009). McMaster, another flotation technique commonly used in veterinary 
parasitology, is an alternative diagnostic tool. The results of a comparative study of four 
techniques, i.e. ether-based concentration, Parasep Solvent Free, McMaster and FLOTAC, 
showed that despite the fact that McMaster was less sensitive than FLOTAC, the former 
technique was the most feasible and easy to perform under field conditions. McMaster 
appeared as a promising technique of choice when using fecal egg counts for monitoring of 
drug efficacy against STHs (Levecke et al., 2009). Overall, several techniques are available 
for the detection of STH infections, with significant difference in the cost, sensitivity, 
simplicity and field applicability. Though a true ‘gold standard’ test with 100% accuracy 
does not exist, Kato–Katz thick smears is so far commonly and widely used as the basic and 
‘default’ technique for helminth epidemiology, despite some limitations. 
Further efforts should be made to validate other detection tools (Tchuem Tchuenté, 2011). The 
choice of a specific diagnostic assay should be governed by the objective of the activity, and 
according to the stage of helminth control (Berquist et al., 2009). As the accuracy of a given 
diagnostic technique may vary significantly according to helminth transmission level, tools 
should be adapted when moving from morbidity control to elimination of infection. Moving 
toward the surveillance and elimination phases requires more sensitive techniques such as 
antibody detection. However, sero-diagnostic tools for detection of helminth infections require 
blood sample collection (invasive), access to affordable, high-quality reagents; which are 
important limiting factors for their integration into large-scale national control programmes. 
These are probably some of the reasons why today only a few countries have adopted 
antibody detection as a key strategy in helminth diagnosis (Berquist et al., 2009). 
4.10 New paradigm shift: Moving from control to elimination 
In the past years, the costs of PZQ and the lack of resources were major constraints for the 
control of schistosomiasis. Today, there exists new impetus for the control, with increasing 
funding opportunity and donated PZQ by pharmaceutical companies. Therefore, there is an 
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opportuny to take up the challenge, to be more ambitious and to move from control to 
elimination where feasible. To do this there is a need to adapt the current threshold for 
intervention (i.e. prevalence > 10%) and to carefully define the implementation unit for PZQ 
mass administration. Treatment algorithms should be re-defined based on current 
knowledge and experiences. 
5. Conclusion 
During the past several decades, many attempts have been made to control schistosomiasis, 
STH and other NTDs. Important advances have been made such as the development of 
praziquantel, albendazole and mebendazole, the current drugs of choice for these NTDs, 
which amplified treatment possibilities to the majority of people who need it. Although few 
control successes were achieved, the global objective is long way off and these diseases 
remain important public health problems in developing countries. Fulfilling the mandate of 
the World Health Assembly resolution 54.19 will require the regular treatment of hundreds 
of millions of children over decades. A successful control of schistosomiasis and STHs 
across the endemic regions calls for strengthening health system and interventions, ensuring 
access to anthelminthic drugs in all health services, co-implementation and the coordinated 
use of the different anthelminthic drugs, promotion of access to safe water, adequate 
sanitation and health education, and mobilization of resources to sustain control activities. 
The challenge also includes an improvement of drug efficacy for a much better rapid impact. 
Indeed, the low cure rate of the recommended drugs for STH, at the single dose as 
commonly used, highlights the need for an alternative strategy based either on a multiple-
days treatment regimen, an alternating use of albendazole and mebendazole from one 
deworming round to another, or the use of an alternative drug. A multiple day treatment 
would obviously increase the costs, but the immediate and long-term benefits would be 
priceless. Today, there exist new impetus to global helminth control and a series of 
favourable factors for implementing successful control programmes. There are several and 
increasing funding opportunities, and we have a great opportunity to properly take up the 
challenge and relieve poor communities from disease burden that jeopardise their 
development. There is an urgent need for well co-ordinated and transparent use of 
multisource funds to increase efficiency and to avoid duplication of efforts. We should act 
cautiously and address the dilemma between costs and efficacy of interventions, and 
between control and elimination. Time is right to act more ambitiously and to set the agenda 
for schistosmiasis and STH elimination. 
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